Summary
This company specializes in developing advanced medical devices for cancer therapy management, particularly focusing on the isolation and analysis of circulating tumor cells (CTCs). Their flagship technology, the CytoCatch™ platform, offers automated solutions for high-efficiency CTC isolation and classification, enabling early cancer diagnosis at reduced costs. The technology is designed to be customizable, allowing researchers to create tailored antibody panels and perform molecular analyses on captured cells.
Based on content on delee.co
foundationmedicine.com
Cambridge, MA
Molecular diagnostics and precision oncology.